• Cisapride (R 51619): Elevating Cardiotoxicity and 5-HT4 Rese

  2026-04-23

  This article advances thought leadership on Cisapride (R 51619) by synthesizing mechanistic insights, deep learning-enabled phenotypic screening, and translational strategy. Drawing from recent high-content screening with iPSC-derived cardiomyocytes and APExBIO's high-purity Cisapride, it offers actionable guidance for researchers aiming to bridge predictive cardiotoxicity with next-generation drug discovery.

• Novel Allosteric PDK4 Inhibitors for Metabolic Disease Thera

  2026-04-22

  This article examines the discovery of new allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, focusing on compound 8c, which demonstrates nanomolar in vitro potency and promising in vivo efficacy against metabolic and allergic disease models. The study introduces a structurally distinct scaffold, providing insight for drug development targeting PDK4-driven pathologies.

• Patient-Derived Gastric Cancer Assembloids Advance Drug Test

  2026-04-22

  This study introduces a patient-specific gastric cancer assembloid model that integrates matched tumor organoids with primary stromal cell subpopulations, closely mimicking the cellular complexity of human tumors. The model enables more predictive drug response profiling and facilitates research into mechanisms of resistance and personalized therapy.

• O-GlcNAcylation Links Wnt Signaling and Osteoblast Metabolis

  2026-04-21

  The referenced study reveals O-GlcNAcylation as an essential mediator of Wnt-stimulated bone formation, demonstrating that this post-translational modification governs glycolytic rewiring and osteoblast differentiation. These insights clarify the metabolic underpinnings of Wnt-driven anabolism and provide new avenues for targeting bone formation disorders.

• CCG-1423: Expanding the Role of RhoA Inhibitors in Junctiona

  2026-04-21

  Explore how CCG-1423, a leading RhoA inhibitor, advances research beyond cancer by enabling precise interrogation of tight junction dynamics and viral entry. Discover insights that set this analysis apart from prior overviews, with actionable protocol guidance and cross-domain context.

• Transcription Termination Limits DNA Damage After WEE1 Inhib

  2026-04-20

  This study reveals that transcription termination plays a crucial role in preventing DNA damage following WEE1 inhibitor treatment, highlighting new mechanisms underlying replication stress in cancer cells. The findings suggest therapeutic opportunities by targeting transcription-replication conflicts to enhance cancer cell death.

• 2-APB and ER-Calcium Dynamics: Decoding Cell Fate under Stre

  2026-04-20

  Discover how 2-APB (2-aminoethoxydiphenyl borate) enables deep investigation of ER-calcium dynamics in programmed cell death. This article uniquely bridges key mechanistic insights to practical assay choices, spotlighting 2-APB’s pivotal role in autophagy-apoptosis research.

• Ceruletide in Pancreatic Function Research: Protocols & Insi

  2026-04-19

  Ceruletide (caerulein) is the gold-standard synthetic peptide for modeling pancreatic fibrosis, acute pancreatitis, and digestive system motility. This article details real-world workflows, advanced troubleshooting, and data-driven protocol refinements, connecting APExBIO’s Ceruletide to the latest breakthroughs in pancreatic fibrosis research.

• FGFR and TGFβ/PI3K/AKT Crosstalk Regulates Periostin in HER2

  2026-04-18

  Labrèche et al. reveal how periostin gene expression in HER2-positive breast cancer cells is governed by intricate crosstalk among FGFR, TGFβ, and PI3K/AKT pathways. This study advances understanding of the molecular mechanisms driving aggressive tumor phenotypes and provides a framework for future therapeutic strategies.

• Anlotinib Hydrochloride: In-Depth Mechanisms and Translation

  2026-04-17

  Explore how Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, advances angiogenesis research through distinct molecular mechanisms and pharmacokinetic advantages. This article delivers technical insights, evidence-based protocol parameters, and practical guidance for cancer research applications.

• Practical Guidance for Okadaic Acid (A4540) in Phosphatase S

  2026-04-16

  Okadaic acid enables selective inhibition of protein phosphatase 1 and 2A, supporting researchers in dissecting phosphorylation-dependent cell signaling and apoptosis induction. It is best suited for mechanistic studies requiring nanomolar precision and is not appropriate for broad-spectrum phosphatase inhibition or assays where off-target effects cannot be controlled.

• SAR405: Vps34 Inhibitor for Precision Autophagy Modulation

  2026-04-15

  SAR405 empowers researchers to dissect autophagy and vesicle trafficking with unmatched selectivity, enabling reproducible, high-sensitivity cellular assays. Its nanomolar potency and specificity for Vps34 make it a cornerstone for studies in cancer and neurodegeneration, as well as for exploring AMPK-ULK1 pathway dynamics.

• PPM-18: Precision iNOS Inhibition for Sepsis & Inflammation

  2026-04-14

  PPM-18 offers targeted, reproducible control of iNOS and NF-κB pathways—empowering researchers in inflammation, sepsis, and immune modulation studies. Explore optimized protocols, troubleshooting guidance, and strategic integration to elevate your experimental outcomes.

• Amphotericin B: Mechanistic Insights for Advanced Antifungal

  2026-04-13

  Explore the molecular mechanism and assay-critical properties of Amphotericin B, a polyene antifungal antibiotic, with a focus on its research applications, sterol interactions, and immune modulation. This article uniquely synthesizes mechanistic, methodological, and protocol-level insights for scientists seeking experimental precision.

• Cerulenin Inhibits Leucomycin Biosynthesis via Polyketide Pa

  2026-04-12

  This study demonstrates that cerulenin, a fatty acid synthesis inhibitor, specifically blocks the biosynthesis of leucomycin, a 16-membered macrolide antibiotic, in Streptomyces kitasatoensis. The findings clarify that macrolide aglycone formation proceeds via a polyketide pathway analogous to fatty acid synthesis, providing mechanistic insight relevant to antibacterial drug resistance research.

442 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page